Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transduction

Abstract

The erbB/HER family of transmembrane receptor tyrosine kinases (RTKs) mediate cellular responses to epidermal growth factor (EGF) and related ligands. We have imaged the early stages of RTK-dependent signaling in living cells using: (i) stable expression of erbB1/2/3 fused with visible fluorescent proteins (VFPs), (ii) fluorescent quantum dots (QDs) bearing epidermal growth factor (EGF-QD) and (iii) continuous confocal laser scanning microscopy and flow cytometry. Here we demonstrate that EGF-QDs are highly specific and potent in the binding and activation of the EGF receptor (erbB1), being rapidly internalized into endosomes that exhibit active trafficking and extensive fusion. EGF-QDs bound to erbB1 expressed on filopodia revealed a previously unreported mechanism of retrograde transport to the cell body. When erbB2-monomeric yellow fluorescent protein (mYFP) or erbB3-monomeric Citrine (mCitrine) were coexpressed with erbB1, the rates and extent of endocytosis of EGF-QD and the RTK-VFP demonstrated that erbB2 but not erbB3 heterodimerizes with erbB1 after EGF stimulation, thereby modulating EGF-induced signaling. QD-ligands will find widespread use in basic research and biotechnological developments.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: QDs bind and activate EGFR, and are endocytosed into living cells.
Figure 2: Live cell activation by EGF-QDs.
Figure 3: Retrograde transport of EGF-QDs on filopodia.
Figure 4: Dynamics of endosomal fusion.
Figure 5: Quantitative analysis of real-time EGF-QD binding and internalization.
Figure 6: Quantitative analysis of EGF-QD–induced erbB1/2/3 internalization.

Similar content being viewed by others

References

  1. Yarden, Y. & Sliwkowski, M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2, 127–137 (2001).

    Article  CAS  Google Scholar 

  2. Jorissen, R.N. et al. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res. 284, 31–53 (2003).

    Article  CAS  Google Scholar 

  3. Schlessinger, J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110, 669–672 (2002).

    Article  CAS  Google Scholar 

  4. Gadella, T.W.J. Jr. & Jovin, T.M. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation. J. Cell Biol. 129, 1543–1558 (1995).

    Article  CAS  Google Scholar 

  5. Moriki, T., Maruyama, H. & Maruyama, I.N. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J. Mol. Biol. 311, 1011–1026 (2001).

    Article  CAS  Google Scholar 

  6. Sako, Y., Minoghchi, S. & Yanagida, T. Single-molecule imaging of EGFR signalling on the surface of living cells. Nat. Cell Biol. 2, 168–172 (2000).

    Article  CAS  Google Scholar 

  7. Hynes, N.E., Horsch, K., Olayioye, M.A. & Badache, A. The ErbB receptor tyrosine family as signal integrators. Endocr. Relat. Cancer 8, 151–159 (2001).

    Article  CAS  Google Scholar 

  8. Jaiswal, J.K., Mattoussi, H., Mauro, J.M. & Simon, S.M. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol. 21, 47–51 (2003).

    Article  CAS  Google Scholar 

  9. Gulliford, T.J., Huang, G.C., Ouyang, X. & Epstein, R.J. Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2. Oncogene 15, 2219–2223 (1997).

    Article  CAS  Google Scholar 

  10. Olayioye, M.A., Beuvink, I., Horsch, K., Daly, J.M. & Hynes, N.E. ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases. J. Biol. Chem. 274, 17209–17218 (1999).

    Article  CAS  Google Scholar 

  11. Cho, H.S. & Leahy, D.J. Structure of the extracellular region of HER3 reveals an interdomain tether. Science 297, 1330–1333 (2002).

    Article  CAS  Google Scholar 

  12. Cho, H.S. et al. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421, 756–760 (2003).

    Article  CAS  Google Scholar 

  13. Ferguson, K.M. et al. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol. Cell 11, 507–517 (2003).

    Article  CAS  Google Scholar 

  14. Garrett, T.P.J. et al. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Mol. Cell 11, 495–505 (2003).

    Article  CAS  Google Scholar 

  15. Ogiso, H. et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110, 775–787 (2002).

    Article  CAS  Google Scholar 

  16. Nagy, P. et al. Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2. J. Cell Sci. 115, 4251–4262 (2002).

    Article  CAS  Google Scholar 

  17. Martin-Fernandez, M., Clarke, D.T., Tobin, M.J., Jones, S.V. & Jones, G.R. Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling. Biophys. J. 82, 2415–2427. (2002).

    Article  CAS  Google Scholar 

  18. Lidke, D.S. et al. Imaging molecular interactions in cells by dynamic and static fluorescence anisotropy (rFLIM and emFRET). Biochem. Soc. Trans. 31, 1020–1027 (2003).

    Article  CAS  Google Scholar 

  19. Deb, T.B. et al. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF. J. Biol. Chem. 276, 15554–15560 (2001).

    Article  CAS  Google Scholar 

  20. Mendrola, J.M., Berger, M.B., King, M.C. & Lemmon, M.A. The single transmembrane domains of erbB receptors self-associate in cell membranes. J. Biol. Chem. 277, 4704–4712 (2002).

    Article  CAS  Google Scholar 

  21. Graus-Porta, D., Beerli, R.R., Daly, J.M. & Hynes, N.E. ErbB-2, the preferred heterodimerization partner of all erbB receptors, is a mediator of lateral signaling. EMBO J. 16, 1647–1655 (1997).

    Article  CAS  Google Scholar 

  22. Wang, Z., Zhang, L., Yeung, T.K. & Chen, X. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation. Mol. Biol. Cell 10, 1621–1636 (1999).

    Article  CAS  Google Scholar 

  23. Wilkinson, J.C. & Staros, J.V. Effect of ErbB2 coexpression on the kinetic interactions of epidermal growth factor with its receptor in intact cells. Biochemistry 41, 8–14 (2002).

    Article  CAS  Google Scholar 

  24. Nagy, P., Arndt-Jovin, D. & Jovin, T.M. Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells. Exp. Cell Res. 285, 39–49 (2003).

    Article  CAS  Google Scholar 

  25. Bridges, A.J. et al. Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. J. Med. Chem. 39, 267–276 (1996).

    Article  CAS  Google Scholar 

  26. Hasson, T. Myosin VI: two distinct roles in endocytosis. J. Cell Sci. 116, 3453–3461 (2003).

    Article  CAS  Google Scholar 

  27. Small, J.V., Stradal, T., Vignal, E. & Rottner, K. The lamellipodium: where motility begins. Trends Cell Biol. 12, 112–120 (2002).

    Article  CAS  Google Scholar 

  28. Sliwkowski, M.X. et al. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem. 269, 14661–14665 (1994).

    CAS  PubMed  Google Scholar 

  29. Dahan, M. et al. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 302, 442–445 (2003).

    Article  CAS  Google Scholar 

  30. Brock, R., Hamelers, I.H. & Jovin, T.M. Comparison of fixation protocols for adherent cultured cells applied to a GFP fusion protein of the epidermal growth factor receptor. Cytometry 35, 353–362 (1999).

    Article  CAS  Google Scholar 

  31. Zacharias, D.A., Violin, J.D., Newton, A.C. & Tsien, R.Y. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296, 913–916 (2002).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The project was supported by funding from the Max Planck Gesellschaft, D.S.L., P.N., R.H by the European Union FP5 Project, J.N.P. by a DFG grant to D.J.A.-J., and E.A.J.-E. by CONICET.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Diane S Lidke or Thomas M Jovin.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1 (PDF 27 kb)

41587_2004_BFnbt929_MOESM2_ESM.mov

Supplementary Movie 1. EGF-QD binding and internalization (Fig2a). Time series of CHO cells expressing erbB1-eGFP (green) with addition of 200 pM 6:1 EGF-QD (red). EGF-QD binding and internalization of the erbB1-eGFP-EGF-QD complex is observed. Note that the cell in the upper left corner undergoes cell division during EGF-QD-erbB1-eGFP endocytosis. 4 s/frame, playback 10 frames/s. Resolution: 0.14 -μm x 0.14 μm. (MOV 3952 kb)

41587_2004_BFnbt929_MOESM3_ESM.mov

Supplementary Movie 2. Z-stack projection of EGF-QD activation and internalization (Fig. 2b). Time series of CHO cells expressing erbB1-eGFP (green) with addition of 250 pM 30:1 EGF-QD (red). Ruffling of the cell surface in response to the EGF-QD binding is seen, followed by extensive internalization. Maximum projection of 12 slices to capture whole cell. 1 min/frame, playback 10 frames/s. _x,y,z: 0.14 μm x 0.14 μm x 0.62 μm. (MOV 556 kb)

41587_2004_BFnbt929_MOESM4_ESM.mov

Supplementary Movie 3. Selective internalization of EGF-QD-erbB1 on erbB3-mCitrine expressing cells (Fig. 3a). Time series of an A431 cell expressing erbB3-mCitrine (green) with addition of 200 pM 6:1 EGF-QD (red). EGF-QDs are seen to bind to the filopodia and travel to the cell body, while the erbB3-mCitrine remains on the cell surface. Maximum projection of 4 slices. 4.5 s/frame, playback 10 frames/s. _x,y,z: 0.1 μm x 0.1 μm x 0.5 μm. (MOV 1076 kb)

41587_2004_BFnbt929_MOESM5_ESM.mov

Supplementary Movie 4. ErbB1-eGFP-EGF-QD endosome fusion (Fig. 4). Time series of a CHO cell expressing erbB1-eGFP (green). Series begins 30 min after addition of 200 pM 6:1 EGF-QD (red). Brownian motion, directed movement and fusion of the erbB1-eGFP-EGF-QD endosomes is observed. Maximum projection of 3 slices. 3.6 s/frame, playback 5 frames/s. _x,y,z: 0.14 μm x 0.14 μm x 0.5 μm. (MOV 585 kb)

Supplementary Methods (PDF 32 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lidke, D., Nagy, P., Heintzmann, R. et al. Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transduction. Nat Biotechnol 22, 198–203 (2004). https://doi.org/10.1038/nbt929

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt929

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing